CENTAUR PHARMACEUTICALS PVT LTD

Overview

CENTAUR PHARMACEUTICALS PVT LTD is an active pharmaceutical ingredient (API) supplier with 34 active FDA Type II Drug Master Files, covering ALPRAZOLAM USP; AZITHROMYCIN DIHYDRATE USP; BRIMONIDINE TARTRATE USP; CHLORDIAZEPOXIDE HCL USP; CHLORDIAZEPOXIDE USP; CHLORZOXAZONE USP.

API / Drug Master Files

CENTAUR PHARMACEUTICALS PVT LTD holds 34 active (36 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LINAGLIPTINActive2022-05-30
• VARENICLINE TARTRATEActive2022-03-30
• FLUPHENAZINE HYDROCHLORIDE USPActive2021-09-23
• TRIAZOLAM USPActive2021-05-17
• CHLORDIAZEPOXIDE HCL USPActive2021-03-25
• ROXITHROMYCIN BPActive2020-07-23
• CLARITHROMYCIN USPActive2020-07-22
• DORZOLAMIDE HYDROCHLORIDE USPActive2020-07-22
• ERYTHROMYCIN ESTOLATE USPActive2020-07-22
• OXYTETRACYCLINE HYDROCHLORIDE USPActive2020-07-22
• OXYTETRACYCLINE DIHYDRATE USPActive2020-03-13
• ERYTHROMYCIN STEARATE USPActive2020-03-12
• AZITHROMYCIN DIHYDRATE USPActive2020-03-09
• ERYTHROMYCIN ETHYLSUCCINATE USPActive2020-03-09
• CHLORZOXAZONE USPActive2017-09-29

Showing 15 of 36 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CENTAUR PHARMACEUTICALS PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.